Clinical Trials Logo

Clinical Trial Summary

A Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05816070
Study type Interventional
Source IVIEW Therapeutics Inc.
Contact
Status Completed
Phase Phase 2
Start date January 5, 2023
Completion date October 12, 2023

See also
  Status Clinical Trial Phase
Completed NCT00347932 - A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Phase 3
Completed NCT00348348 - A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Phase 3
Not yet recruiting NCT01227915 - Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis Phase 3